Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

A prospective study of tea drinking temperature and risk of esophageal squamous cell carcinoma.

Islami F, Poustchi H, Pourshams A, Khoshnia M, Gharavi A, Kamangar F, Dawsey SM, Abnet CC, Brennan P, Sheikh M, Sotoudeh M, Nikmanesh A, Merat S, Etemadi A, Nasseri Moghaddam S, Pharoah PD, Ponder BA, Day NE, Jemal A, Boffetta P, Malekzadeh R.

Int J Cancer. 2019 Mar 20. doi: 10.1002/ijc.32220. [Epub ahead of print]

PMID:
30891750
2.

Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting.

Sharafi H, Poustchi H, Azimian F, Tamadoni B, Ramezani R, Gouya MM, Sheikh M, Hashemi F, Tashakorian M, Alasvand R, Alavian SM, Merat S.

J Clin Virol. 2019 Apr;113:20-23. doi: 10.1016/j.jcv.2019.02.005. Epub 2019 Feb 25.

PMID:
30825832
3.

Longitudinal Analyses of Gut-Associated Bacterial Microbiota in Ulcerative Colitis Patients.

Al-Bayati L, Nayeri Fasaei B, Merat S, Bahonar A.

Arch Iran Med. 2018 Dec 1;21(12):578-584.

4.

MSLN (Mesothelin), ANTXR1 (TEM8), and MUC3A are the potent antigenic targets for CAR T cell therapy of gastric adenocarcinoma.

Sotoudeh M, Shirvani SI, Merat S, Ahmadbeigi N, Naderi M.

J Cell Biochem. 2019 Apr;120(4):5010-5017. doi: 10.1002/jcb.27776. Epub 2018 Sep 27.

PMID:
30260046
5.

Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis.

Fadaei R, Poustchi H, Meshkani R, Moradi N, Golmohammadi T, Merat S.

Sci Rep. 2018 Aug 3;8(1):11691. doi: 10.1038/s41598-018-29639-5.

6.

Prevalence and Clinical Outcomes of Common Bile Duct Dilation in Patients Who Use Opium.

Radmard AR, Khorasanizadeh F, Poustchi H, Kooraki S, Mirminachi B, Sharafkhah M, Jafari E, Hashemi Taheri AP, Sotoudehmanesh R, Mohamadnejad M, Malekzadeh R, Merat S.

Am J Med Sci. 2018 Jul;356(1):39-46. doi: 10.1016/j.amjms.2018.04.003. Epub 2018 Apr 7.

PMID:
30049329
7.

Causes of premature death and their associated risk factors in the Golestan Cohort Study, Iran.

Nalini M, Oranuba E, Poustchi H, Sepanlou SG, Pourshams A, Khoshnia M, Gharavi A, Dawsey SM, Abnet CC, Boffetta P, Brennan P, Sotoudeh M, Nikmanesh A, Merat S, Etemadi A, Shakeri R, Sohrabpour AA, Nasseri-Moghaddam S, Kamangar F, Malekzadeh R.

BMJ Open. 2018 Jul 18;8(7):e021479. doi: 10.1136/bmjopen-2018-021479.

8.

Feasibility of Colon Cancer Screening by Fecal Immunochemical Test in Iran.

Salimzadeh H, Bishehsari F, Sauvaget C, Amani M, Hamzehloo G, Nikfarjam A, Merat S, Delavari A, Malekzadeh R.

Arch Iran Med. 2017 Dec 1;20(12):726-733.

9.

Association of carotid intima media thickness with atherogenic index of plasma, apo B/apo A-I ratio and paraoxonase activity in patients with non-alcoholic fatty liver disease.

Fadaei R, Meshkani R, Poustchi H, Fallah S, Moradi N, Panahi G, Merat S, Golmohammadi T.

Arch Physiol Biochem. 2019 Feb;125(1):19-24. doi: 10.1080/13813455.2018.1429475. Epub 2018 Jan 23.

PMID:
29359590
10.

Opium Use and Risk of Pancreatic Cancer: A Prospective Cohort Study.

Moossavi S, Mohamadnejad M, Pourshams A, Poustchi H, Islami F, Sharafkhah M, Mirminachi B, Nasseri-Moghaddam S, Semnani S, Shakeri R, Etemadi A, Merat S, Khoshnia M, Dawsey SM, Pharoah PD, Brennan P, Abnet CC, Boffetta P, Kamangar F, Malekzadeh R.

Cancer Epidemiol Biomarkers Prev. 2018 Mar;27(3):268-273. doi: 10.1158/1055-9965.EPI-17-0592. Epub 2017 Dec 20.

11.

Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial.

Mofidi F, Poustchi H, Yari Z, Nourinayyer B, Merat S, Sharafkhah M, Malekzadeh R, Hekmatdoost A.

Br J Nutr. 2017 Mar;117(5):662-668. doi: 10.1017/S0007114517000204. Epub 2017 Mar 27.

PMID:
28345499
12.

Two Triacylglycerol Pathway Genes, CTDNEP1 and LPIN1, are Down-Regulated by hsa-miR-122-5p in Hepatocytes.

Naderi M, Pazouki A, Arefian E, Hashemi SM, Jamshidi-Adegani F, Gholamalamdari O, Soudi S, Azadmanesh K, Mirab Samiee S, Merat S, Gholami Fesharaki M, Mondanizadeh M, Vasei M, Soleimani M.

Arch Iran Med. 2017 Mar;20(3):165-171. doi: 0172003/AIM.009.

13.

Role of serum level and genetic variation of IL-28B in interferon responsiveness and advanced liver disease in chronic hepatitis C patients.

Alborzi A, Hashempour T, Moayedi J, Musavi Z, Pouladfar G, Merat S.

Med Microbiol Immunol. 2017 Apr;206(2):165-174. doi: 10.1007/s00430-017-0497-y. Epub 2017 Feb 18.

PMID:
28214926
14.

The Presence of Autoantibodies to Cytoplasmic Rod and Ring Particles in the Serum of Patients with Chronic Hepatitis C Virus Infection.

Afsharzadeh F, Bokharaei-Salim F, Esghaei M, Monavari SH, Merat S, Poustchi H, Haj-Sheykholeslami A, Keyvani H.

Hepat Mon. 2016 Dec 11;16(12):e42388. doi: 10.5812/hepatmon.42388. eCollection 2016 Dec.

15.

Central Obesity and Liver Iron Content: A Noninvasive Assessment in General Population by Magnetic Resonance Imaging.

Radmard AR, Poustchi H, Hashemi Taheri AP, Gerami Seresht M, Mohammadinejad P, Yoonessi A, Dadgostar M, Rahmanian MS, Jafari E, Zeinoddini A, Malekzadeh R, Merat S.

Ann Nutr Metab. 2016;69(3-4):181-189. doi: 10.1159/000453111. Epub 2016 Nov 18.

PMID:
27855393
16.

Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline.

Alavian SM, Hajarizadeh B, Bagheri Lankarani K, Sharafi H, Ebrahimi Daryani N, Merat S, Mohraz M, Mardani M, Fattahi MR, Poustchi H, Nikbin M, Nabavi M, Adibi P, Ziaee M, Behnava B, Rezaee-Zavareh MS, Colombo M, Massoumi H, Bizri AR, Eghtesad B, Amiri M, Namvar A, Hesamizadeh K, Malekzadeh R.

Hepat Mon. 2016 Aug 13;16(8):e40959. eCollection 2016 Aug. Review.

17.

Assessment of Abdominal Fat Distribution in Non-Alcoholic Fatty Liver Disease by Magnetic Resonance Imaging: a Population-based Study.

Radmard AR, Rahmanian MS, Abrishami A, Yoonessi A, Kooraki S, Dadgostar M, Hashemi Taheri AP, Gerami Seresht M, Poustchi H, Jafari E, Malekzadeh R, Merat S.

Arch Iran Med. 2016 Oct;19(10):693-699.

18.

Liver Disease Burden of Hepatitis C Virus Infection in Iran and the Potential Impact of Various Treatment Strategies on the Disease Burden.

Hajarizadeh B, Razavi-Shearer D, Merat S, Alavian SM, Malekzadeh R, Razavi H.

Hepat Mon. 2016 Jun 14;16(7):e37234. doi: 10.5812/hepatmon.37234. eCollection 2016 Jul.

19.

Reliability Analysis of a Newly Developed Questionnaire for Quality Control of Follow-up Visits in PolyIran Study.

Roshandel G, Ostovaneh MR, Poustchi H, Malekzadeh F, Sepanlou SG, Honarvar MR, Semnani S, Merat S, Malekzadeh R.

Arch Iran Med. 2016 Aug;19(8):551-5. doi: 0161908/AIM.006.

20.

Effects of Pomegranate and Orange Juice on Antioxidant Status in Non-Alcoholic Fatty Liver Disease Patients: A Randomized Clinical Trial.

Ekhlasi G, Shidfar F, Agah S, Merat S, Hosseini AF.

Int J Vitam Nutr Res. 2015 Dec;85(5-6):292-298. doi: 10.1024/0300-9831/a000292. Epub 2016 Jul 14.

PMID:
27414418
21.

Effects of Synbiotics Supplementation in Lean Patients with Nonalcoholic Fatty Liver Disease: Study Protocol of a Pilot Randomized Double-blind Clinical Trial.

Mofidi F, Yari Z, Poustchi H, Merat S, Nourinayyer B, Malekzadeh R, Hekmatdoost A.

Arch Iran Med. 2016 Apr;19(4):282-4. doi: 0161904/AIM.000010.

22.

Abdominal fat distribution and carotid atherosclerosis in a general population: a semi-automated method using magnetic resonance imaging.

Radmard AR, Poustchi H, Ansari L, Khorasanizadeh F, Yoonessi A, Hashemi Taheri AP, Rahmanian MS, Jafari E, Malekzadeh R, Merat S.

Jpn J Radiol. 2016 Jun;34(6):414-22. doi: 10.1007/s11604-016-0540-8. Epub 2016 Mar 25.

PMID:
27015838
23.

Nut consumption and total and cause-specific mortality: results from the Golestan Cohort Study.

Eslamparast T, Sharafkhah M, Poustchi H, Hashemian M, Dawsey SM, Freedman ND, Boffetta P, Abnet CC, Etemadi A, Pourshams A, Malekshah AF, Islami F, Kamangar F, Merat S, Brennan P, Hekmatdoost A, Malekzadeh R.

Int J Epidemiol. 2017 Feb 1;46(1):75-85. doi: 10.1093/ije/dyv365.

24.

Emerging Epidemic of Inflammatory Bowel Disease in a Middle Income Country: A Nation-wide Study from Iran.

Malekzadeh MM, Vahedi H, Gohari K, Mehdipour P, Sepanlou SG, Ebrahimi Daryani N, Zali MR, Mansour-Ghanaei F, Safaripour A, Aghazadeh R, Vossoughinia H, Fakheri H, Somi MH, Maleki I, Hoseini V, Ghadir MR, Daghaghzadeh H, Adibi P, Tavakoli H, Taghavi A, Zahedi MJ, Amiriani T, Tabib M, Alipour Z, Nobakht H, Yazdanbod A, Sadreddini M, Bakhshipour A, Khosravi A, Khosravi P, Nasseri-Moghaddam S, Merat S, Sotoudehmanesh R, Barazandeh F, Arab P, Baniasadi N, Pournaghi SJ, Parsaeian M, Farzadfar F, Malekzadeh R.

Arch Iran Med. 2016 Jan;19(1):2-15. doi: 0161901/AIM.003. Review.

25.

Mean Polyp per Patient Is an Accurate and Readily Obtainable Surrogate for Adenoma Detection Rate: Results from an Opportunistic Screening Colonoscopy Program.

Delavari A, Salimzadeh H, Bishehsari F, Sobh Rakhshankhah E, Delavari F, Moossavi S, Khosravi P, Nasseri-Moghaddam S, Merat S, Ansari R, Vahedi H, Shahbazkhani B, Saberifiroozi M, Sotoudeh M, Malekzadeh R.

Middle East J Dig Dis. 2015 Oct;7(4):214-9.

26.

Minimum Requirements for Reporting Fecal Microbiota Transplant Trial.

Moossavi S, Bishehsari F, Ansari R, Vahedi H, Nasseri-Moghaddam S, Merat S, Sobhani I, Keshavarzian A, Malekzadeh R.

Middle East J Dig Dis. 2015 Jul;7:177-80. No abstract available.

27.

Physicians' Knowledge and Attitude Towards Fecal Microbiota Transplant in Iran.

Moossavi S, Salimzadeh H, Katoonizadeh A, Mojarrad A, Merat D, Ansari R, Vahedi H, Merat S, Malekzadeh R.

Middle East J Dig Dis. 2015 Jul;7:155-60.

28.

Central Obesity and Advanced Liver Stiffness in Hepatitis B: Result from Golestan Hepatitis B Cohort Study.

Besharat S, Poustchi H, Mohamadkhani A, Roshandel G, Freedman ND, Merat S, Malekzadeh R.

Arch Iran Med. 2015 Sep;18(9):562-6. doi: 0151809/AIM.003.

29.

PolyPill for Prevention of Cardiovascular Disease in an Urban Iranian Population with Special Focus on Nonalcoholic Steatohepatitis: A Pragmatic Randomized Controlled Trial within a Cohort (PolyIran - Liver) - Study Protocol.

Merat S, Poustchi H, Hemming K, Jafari E, Radmard AR, Nateghi A, Shiravi Khuzani A, Khoshnia M, Marshall T, Malekzadeh R.

Arch Iran Med. 2015 Aug;18(8):515-23. doi: 015188/AIM.009.

30.

Gallstone disease and obesity: a population-based study on abdominal fat distribution and gender differences.

Radmard AR, Merat S, Kooraki S, Ashraf M, Keshtkar A, Sharafkhah M, Jafari E, Malekzadeh R, Poustchi H.

Ann Hepatol. 2015 Sep-Oct;14(5):702-9.

31.

Detection of Specific Antibodies to HCV-ARF/CORE+1 Protein in Cirrhotic and Non-Cirrhotic Patients with Hepatitis C: A Possible Association with Progressive Fibrosis.

Ajorloo M, Bamdad T, Hashempour T, Alborzi AM, Mozhgani SH, Asadi R, Haj-sheykholeslami A, Merat S.

Arch Iran Med. 2015 May;18(5):304-7. doi: 0151805/AIM.008.

32.

F protein increases CD4+CD25+ T cell population in patients with chronic hepatitis C.

Hashempour T, Bamdad T, Bergamini A, Lavergne JP, Haj-Sheykholeslami A, Brakier-Gingras L, Ajorloo M, Merat S.

Pathog Dis. 2015 Jun;73(4). pii: ftv022. doi: 10.1093/femspd/ftv022. Epub 2015 Apr 9.

PMID:
25862675
33.

Liver enzyme levels and hepatic iron content in Fatty liver: a noninvasive assessment in general population by T2* mapping.

Radmard AR, Poustchi H, Dadgostar M, Yoonessi A, Kooraki S, Jafari E, Hashemi Taheri AP, Malekzadeh R, Merat S.

Acad Radiol. 2015 Jun;22(6):714-21. doi: 10.1016/j.acra.2015.01.011. Epub 2015 Mar 7.

PMID:
25754799
34.

The relationship between HLA-G and viral loads in non-responder HCV-infected patients after combined therapy with IFN-α2α and ribavirin.

Khorrami S, Mohammadpour H, Shahzamani K, Zarif MN, Sharifi AH, Merat S, Poustchi H.

Hum Immunol. 2015 Mar;76(2-3):181-6. doi: 10.1016/j.humimm.2014.12.012. Epub 2014 Dec 11.

PMID:
25500249
35.

Adenoma detection rates in an opportunistic screening colonoscopy program in Iran, a country with rising colorectal cancer incidence.

Delavari A, Bishehsari F, Salimzadeh H, Khosravi P, Delavari F, Nasseri-Moghaddam S, Merat S, Ansari R, Vahedi H, Shahbazkhani B, Saberifiroozi M, Sotoudeh M, Malekzadeh R.

BMC Gastroenterol. 2014 Nov 18;14:196. doi: 10.1186/s12876-014-0196-8.

36.

Cohort profile: golestan hepatitis B cohort study- a prospective long term study in northern iran ​.

Poustchi H, Katoonizadeh A, Ostovaneh MR, Moossavi S, Sharafkhah M, Esmaili S, Pourshams A, Mohamadkhani A, Besharat S, Merat S, Mohamadnejad M, George J, Malekzadeh R.

Middle East J Dig Dis. 2014 Oct;6(4):186-94.

37.

Polypill for the prevention of cardiovascular disease (PolyIran): study design and rationale for a pragmatic cluster randomized controlled trial.

Ostovaneh MR, Poustchi H, Hemming K, Marjani H, Pourshams A, Nateghi A, Majed M, Navabakhsh B, Khoshnia M, Jaafari E, Mohammadifard N, Malekzadeh F, Merat S, Sadeghi M, Naemi M, Etemadi A, Thomas GN, Sarrafzadegan N, Cheng KK, Marshall T, Malekzadeh R.

Eur J Prev Cardiol. 2015 Dec;22(12):1609-17. doi: 10.1177/2047487314550803. Epub 2014 Sep 17.

38.

Clinical and pathological features of non-functional neuroendocrine tumors of pancreas: a report from iran.

Nozari N, Nikfam S, Nikmanesh A, Mohammadnejad M, Sotoudehmanesh R, Zamani F, Merat S, Malekzadeh R, Pourshams A.

Middle East J Dig Dis. 2014 Jul;6(3):151-5.

39.

Characteristics of colorectal polyps and cancer; a retrospective review of colonoscopy data in iran.

Delavari A, Mardan F, Salimzadeh H, Bishehsari F, Khosravi P, Khanehzad M, Nasseri-Moghaddam S, Merat S, Ansari R, Vahedi H, Shahbazkhani B, Saberifiroozi M, Sotoudeh M, Malekzadeh R.

Middle East J Dig Dis. 2014 Jul;6(3):144-50.

40.

Contact with ruminants is associated with esophageal squamous cell carcinoma risk.

Nasrollahzadeh D, Ye W, Shakeri R, Sotoudeh M, Merat S, Kamangar F, Abnet CC, Islami F, Boffetta P, Dawsey SM, Brennan P, Malekzadeh R.

Int J Cancer. 2015 Mar 15;136(6):1468-74. doi: 10.1002/ijc.29109. Epub 2014 Aug 14.

41.

Therapeutic effects, tolerability and safety of a multi-strain probiotic in Iranian adults with irritable bowel syndrome and bloating.

Jafari E, Vahedi H, Merat S, Momtahen S, Riahi A.

Arch Iran Med. 2014 Jul;17(7):466-70. doi: 0141707/AIM.003.

42.

Oral Nitrate Reductase Activity Is Not Associated with Development of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Pilot Study.

Barzin G, Merat S, Nokhbeh-Zaeem H, Saniee P, Pedramnia S, Mostashfi Habibabadi A, Nasseri-Moghaddam S.

Middle East J Dig Dis. 2014 Jan;6(1):23-7.

43.

Efficacy of adding metformin to pegylated interferon and ribavirin in treatment naïve patients with chronic hepatitis C: a randomized double-blind controlled trial.

Sharifi AH, Mohammadi M, Fakharzadeh E, Zamini H, Zaer-Rezaee H, Jabbari H, Merat S.

Middle East J Dig Dis. 2014 Jan;6(1):13-7.

44.

Seroprevalence of Hepatitis A among Students Enrolled in Tehran University of Medical Sciences during 2011.

Rabiee A, Nikayin S, Hashemi SR, Mohaghegh M, Amini M, Rabiee R, Merat S.

Middle East J Dig Dis. 2013 Jul;5(3):137-40.

45.

Endoscopic screening for precancerous lesions of the esophagus in a high risk area in Northern Iran.

Roshandel G, Khoshnia M, Sotoudeh M, Merat S, Etemadi A, Nickmanesh A, Norouzi A, Pourshams A, Poustchi H, Semnani S, Ghasemi-Kebria F, Noorbakhsh R, Abnet C, Dawsey SM, Malekzadeh R.

Arch Iran Med. 2014 Apr;17(4):246-52. doi: 014174/AIM.006.

46.

Determinants of gastroesophageal reflux disease, including hookah smoking and opium use- a cross-sectional analysis of 50,000 individuals.

Islami F, Nasseri-Moghaddam S, Pourshams A, Poustchi H, Semnani S, Kamangar F, Etemadi A, Merat S, Khoshnia M, Dawsey SM, Pharoah PD, Brennan P, Abnet CC, Boffetta P, Malekzadeh R.

PLoS One. 2014 Feb 21;9(2):e89256. doi: 10.1371/journal.pone.0089256. eCollection 2014.

47.

Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.

Eslami L, Merat S, Malekzadeh R, Nasseri-Moghaddam S, Aramin H.

Cochrane Database Syst Rev. 2013 Dec 27;(12):CD008623. doi: 10.1002/14651858.CD008623.pub2. Review.

PMID:
24374462
48.

Development and Application of an In-house Line Probe Assay for Hepatitis C Virus Genotyping.

Majidzadeh-A K, Morovvati A, Soleimani M, Langeroudi AG, Merat S, Jabbari H.

Hepat Mon. 2013 Apr 30;13(5):e6767. doi: 10.5812/hepatmon.6767. Print 2013 May.

49.

Endoscopic screening for esophageal squamous cell carcinoma.

Roshandel G, Nourouzi A, Pourshams A, Semnani S, Merat S, Khoshnia M.

Arch Iran Med. 2013 Jun;16(6):351-7. doi: 013166/AIM.009. Review.

50.

Marked increase in the incidence rate of esophageal adenocarcinoma in a high-risk area for esophageal cancer.

Ghasemi-Kebria F, Roshandel G, Semnani S, Shakeri R, Khoshnia M, Naeimi-Tabiei M, Merat S, Malekzadeh R.

Arch Iran Med. 2013 Jun;16(6):320-3. doi: 013166/AIM.003.

Supplemental Content

Loading ...
Support Center